Randi Hovland

3.7k citations

69 papers · 2.3k indexed · 1 hit paper · h-index 28

Molecular Biology top 5%
Hematology top 1%
Oncology top 10%
Public Health, Environmental and Occupational Health top 5%
Cancer Research top 10%

Co-authors: Bjørn Tore Gjertsen Øystein Bruserud Garry P. Nolan Jonathan M. Irish Omar D. Perez Peter O. Krutzik Stein Ove Døskeland Håkon Reikvam
Topics: Acute Myeloid Leukemia Research (27 papers)Acute Lymphoblastic Leukemia research (13 papers)Chronic Myeloid Leukemia Treatments (12 papers)
Cited by: Hematology Genetics Cancer Research
Journals: Cell Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: Norway Sweden Denmark

In The Last Decade

Randi Hovland

68 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells

2004 546 citations Jonathan M. Irish, Randi Hovland et al. Cell profile →

Peers

Countries citing papers authored by Randi Hovland

Since Specialization

Citations

This map shows the geographic impact of Randi Hovland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randi Hovland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randi Hovland more than expected).

Fields of papers citing papers by Randi Hovland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randi Hovland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randi Hovland. The network helps show where Randi Hovland may publish in the future.

Co-authorship network of co-authors of Randi Hovland

This figure shows the co-authorship network connecting the top 25 collaborators of Randi Hovland. A scholar is included among the top collaborators of Randi Hovland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randi Hovland. Randi Hovland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of postoperative circulating tumour DNA to predict early recurrence in patients with stage I–III right-sided colon cancer: prospective observational study 2024 ·BJS Open ·(unknown),(unknown),(unknown),(unknown),Geir Egil Eide,Bjørn Tore Gjertsen,F. Pfeffer,Randi Hovland	3
2	DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML) 2021 ·Genes ·(unknown),Josefine Palle,Christofer Bäcklin,Jonas Abrahamsson,Ulrika Norén‐Nyström,Henrik Hasle,Kirsi Jahnukainen,Ólafur Gísli Jónsson,Randi Hovland,Birgitte Lausen,Rolf Larsson,Lars Palmqvist,Anna Staffas,Bernward Zeller,Jessica Nordlund	9
3	KRAS mutation analysis by droplet digital PCR of duodenal juice from patients with MODY8 and other pancreatic diseases 2021 ·Pancreatology ·(unknown),Erling Tjora,(unknown),Trond Engjom,Helge Ræder,Randi Hovland,Anders Molven	1
4	Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment 2020 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Randi Hovland,(unknown),Øystein Bruserud,Håkon Reikvam	2
5	Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up 2019 ·HemaSphere ·Panagiotis Baliakas,Bianca Tesi,Ulla Wartiovaara‐Kautto,Asbjørg Stray‐Pedersen,Lone Smidstrup Friis,Ingunn Dybedal,Randi Hovland,Kirsi Jahnukainen,Klas Raaschou‐Jensen,Per Ljungman,Cecilie F. Rustad,Charlotte Kvist Lautrup,Outi Kilpivaara,Astrid Olsnes Kittang,Kirsten Grønbæk,Jörg Cammenga,Eva Hellström‐Lindberg,Mette Klarskov Andersen	53
6	Generation of Prostate Tumor–Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling 2013 ·Cancer Research ·Yi Qu,Anne M. Øyan,Runhui Liu,(unknown),Jigang Zhang,Randi Hovland,Mihaela Popa,Xiaojun Liu,Karl A. Brokstad,Ronald Simon,Anders Molven,Biaoyang Lin,Weidong Zhang,Emmet McCormack,Karl‐Henning Kalland,Xisong Ke	61
7	Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications 2011 ·BioMed Research International ·Håkon Reikvam,Kimberley Joanne Hatfield,Astrid Olsnes Kittang,Randi Hovland,Øystein Bruserud	68
8	Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status – consequences and potentials for pharmacological intervention 2011 ·British Journal of Haematology ·Håkon Reikvam,Kimberley Joanne Hatfield,Elisabeth Ersvær,Randi Hovland,Jørn Skavland,Bjørn Tore Gjertsen,Kjell Petersen,(unknown)	38
9	Loss-of-Function <i>CNKSR2</i> Mutation Is a Likely Cause of Non-Syndromic X-Linked Intellectual Disability 2011 ·Molecular Syndromology ·Gunnar Houge,(unknown),Randi Hovland	39
10	Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia 2011 ·Oncogene ·Nina Ånensen,(unknown),Werner Van Belle,Ingvild Haaland,(unknown),Jean‐Christophe Bourdon,Randi Hovland,Kjetil Taskén,Stian Knappskog,Per Eystein Lønning,Øyvind Bruserud,Bjørn Tore Gjertsen	51
11	Paediatric B‐cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols 2011 ·British Journal of Haematology ·Mette Klarskov Andersen,K. Autio,Gisela Barbany,Georg Borgström,Lucia Cavelier,Irina Golovleva,Sverre Heim,(unknown),Randi Hovland,Jóhann Heiðar Jóhannsson,Bertil Johansson,Eigil Kjeldsen,Ann Nordgren,Lars Palmqvist,Erik Forestier	24
12	<i>PHF6</i> Deletions May Cause Borjeson-Forssman-Lehmann Syndrome in Females 2010 ·Molecular Syndromology ·Siren Berland,(unknown),(unknown),Gunnar Houge,Randi Hovland	28
13	Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model 2010 ·Experimental Cell Research ·Xisong Ke,Wencheng Li,Randi Hovland,Yi Qu,Runhui Liu,Emmet McCormack,Frits Thorsen,Jan Roger Olsen,Anders Molven,Ira Kogan-Sakin,Varda Rotter,Lars A. Akslen,Anne M. Øyan,Karl‐Henning Kalland	14
14	Outcome of ETV6/RUNX1‐positive childhood acute lymphoblastic leukaemia in the NOPHO‐ALL‐1992 protocol: frequent late relapses but good overall survival 2008 ·British Journal of Haematology ·Erik Forestier,Mats Heyman,Mette K. Andersen,K. Autio,Elisabeth Blennow,Georg Borgström,Irina Golovleva,Sverre Heim,(unknown),Randi Hovland,Jóhann Heiðar Jóhannsson,Gitte Kerndrup,Ann Nordgren,Richard Rosenquist,Birgitta Swolin,Bertil Johansson,(unknown)	60
15	Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation 2008 ·PLoS ONE ·Xisong Ke,Yi Qu,Naomi Goldfinger,Kari Rostad,Randi Hovland,Lars A. Akslen,Varda Rotter,Anne M. Øyan,Karl‐Henning Kalland	49
16	Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)‐positive B‐cell precursor acute lymphoblastic leukemias: A nordic series of 24 cases and review of the literature 2007 ·Genes Chromosomes and Cancer ·Erik Forestier,(unknown),Mette K. Andersen,K. Autio,Georg Borgström,Irina Golovleva,Britt Gustafsson,Sverre Heim,(unknown),Mats Heyman,Randi Hovland,Jóhann Heiðar Jóhannsson,Gitte Kerndrup,Richard Rosenquist,Jacqueline Schoumans,Birgitta Swolin,Bertil Johansson,Ann Nordgren	22
17	Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels 2007 ·Leukemia ·Kimberley Joanne Hatfield,Randi Hovland,Anne M. Øyan,Karl‐Henning Kalland,Anita Ryningen,Bjørn Tore Gjertsen,Øystein Bruserud	47
18	High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B‐cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989–2005 2006 ·British Journal of Haematology ·Kristina Karrman,Erik Forestier,Mette K. Andersen,K. Autio,Georg Borgström,Sverre Heim,(unknown),Randi Hovland,Gitte Kerndrup,Bertil Johansson,(unknown)	8
19	Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cellsbreakdown → 2004 ·Cell ·Jonathan M. Irish,Randi Hovland,Peter O. Krutzik,Omar D. Perez,Øystein Bruserud,Bjørn Tore Gjertsen,Garry P. Nolan	546
20	Analysis of Acute Myelogenous Leukemia: Preparation of Samples for Genomic and Proteomic Analyses 2002 ·Journal of Hematotherapy & Stem Cell Research ·Bjørn Tore Gjertsen,Anne M. Øyan,Bruz Marzolf,Randi Hovland,Gro Gausdal,Stein Ove Døskeland,Krassen Dimitrov,Allison Golden,Karl‐Henning Kalland,Leroy Hood,Øystein Bruserud	37

About Randi Hovland

Randi Hovland is a scholar working on Hematology, Genetics and Cancer Research, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (13 papers) and Chronic Myeloid Leukemia Treatments (12 papers). The work is most often cited by research in Hematology (873 citations), Genetics (249 citations) and Cancer Research (291 citations). Randi Hovland has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Bjørn Tore Gjertsen, Øystein Bruserud, Garry P. Nolan, Jonathan M. Irish, Omar D. Perez, Peter O. Krutzik, Stein Ove Døskeland, Håkon Reikvam, Gunnar Houge and Anne M. Øyan. Their work appears in journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact